Plasma cell vulvitis: A case report.

Clindamycin Clobetasone Estriol Lichen sclerosis Plasma cell vulvitis Zoons vulvitis

Journal

Case reports in women's health
ISSN: 2214-9112
Titre abrégé: Case Rep Womens Health
Pays: Netherlands
ID NLM: 101682122

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 01 03 2024
revised: 24 03 2024
accepted: 25 03 2024
medline: 5 4 2024
pubmed: 5 4 2024
entrez: 5 4 2024
Statut: epublish

Résumé

Plasma cell vulvitis (PCV) is a rare inflammatory condition characterised by plasma cell infiltration in the vulva. A woman in her 80s was referred to a specialist gynaecology clinic with chronic, painful vulval ulcers that were non-responsive to topical betamethasone. Following a biopsy confirming PCV, combination therapy was initiated. This included non-pharmacological management, such as promoting aeration and using hypoallergenic clothing and washes, combined with the daily application of clobetasone cream 0.05% and clindamycin cream 0.1%. Additionally, topical estriol 1% was applied twice weekly. The patient experienced rapid symptom resolution, with the PCV lesion healing within six weeks of starting treatment. This case documents the rare occurrence of plasma cell vulvitis presenting as chronic vulval ulceration, and proposes a treatment regimen worth considering in instances where monotherapy has been ineffective.

Identifiants

pubmed: 38577172
doi: 10.1016/j.crwh.2024.e00601
pii: S2214-9112(24)00022-5
pmc: PMC10987320
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e00601

Informations de copyright

© 2024 Published by Elsevier B.V.

Auteurs

Lauren Fisher (L)

Fiona Stanley Hospital, Perth, WA, Australia.

Eman Alnaggar (E)

St John of God Hospital, Murdoch, Australia.

Classifications MeSH